scholarly journals Perfusion MR prior to radiotherapy is a strong predictor of survival in high-grade gliomas after proton and carbon ion radiotherapy

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Xianxin Qiu ◽  
Jing Gao ◽  
Jing Yang ◽  
Jiyi Hu ◽  
Weixu Hu ◽  
...  

2013 ◽  
Vol 108 (1) ◽  
pp. 132-135 ◽  
Author(s):  
Stephanie E. Combs ◽  
Thomas Bruckner ◽  
Jun-Etso Mizoe ◽  
Tadashi Kamada ◽  
Hirohiko Tsujii ◽  
...  


2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Xianxin Qiu ◽  
Jing Gao ◽  
Jing Yang ◽  
Jiyi Hu ◽  
Weixu Hu ◽  
...  


Author(s):  
T. Kamada ◽  
R. Imai ◽  
S. Sugawara ◽  
H. Tsuji ◽  
H. Tsujii


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Charlotte Debus ◽  
Maria Waltenberger ◽  
Ralf Floca ◽  
Ali Afshar-Oromieh ◽  
Nina Bougatf ◽  
...  




Author(s):  
T.B. Nguye

New enhancing lesions after surgery and chemoradiation for high grade glioma commonly contain variable proportions of tumor recurrence (TR), tissue necrosis and treatment related changes. Our purpose is to determine whether the pattern of contrast enhancement and perfusion MR parameters correlate with the percentage of TR in these lesions. Methods: We prospectively enrolled 30 patients with high grade gliomas who presented with a new enhancing lesion suspicious for tumor recurrence. Each patient underwent conventional MRI with DCE and DSC perfusion MRI. The pattern of enhancement was classified by a blinded neuroradiologist in 5 different categories (solid, focal nodular, peripheral rim, hazy, punctate). A hot spot region-of-interest analysis was performed for each parametric map (Ktrans, AUC, Vp, corrected CBV). TR percentage was defined histopathologically. The lesions were categorized into predominant TR (=tumor>70%), predominant treatment related changes (T=<35%) and mixed lesions (35 %< T=<70%). Differences between the groups were assessed via Kruskal-Wallis and Mann-Whitney U tests. Results: There were 32 lesions (4 predominantly treatment related lesions,5 mixed lesions,23 predominant tumor recurrence). There is no significant difference in the enhancement pattern between the three groups (p=0.18).Statistically significant difference was only seen for corrected CBV between the three groups (p=0.01), mainly between the mixed and predominant tumor groups. The rest of the perfusion parameters did not show a statistically significant difference between the groups(p>0.05). Conclusion: Corrected CBV might be useful in predicting the proportion of tumor recurrence in post-treatment high grade gliomas.



2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 2043-2043
Author(s):  
Patrick Salome ◽  
Francesco Sforazzini ◽  
Andreas Kudak ◽  
Laila König ◽  
Philipp Kickingereder ◽  
...  

2043 Background: Unique radiobiological and physical properties of carbon ion radiotherapy (CIRT) may be favorably utilized to improve outcome in recurrent High-Grade Glioma (rHGG). There are currently no standardized criteria for stratification of rHGG patients for re-irradiation (re-RT). This study evaluated the impact of morphological data (radiomics) and physical information (dosiomics) in stratifying rHGG patients for CIRT. Methods: Quantitative radiomics and dosiomics features were extracted from CIRT planning CTs with dose distribution (DD) and multiparametric MRIs (mpMRI, pre re-RT) of 141 patients (recurrent grade III: n=56 40%, grade IV: n=85 60%) treated with a median dose of 42 Gy (RBE) and a median fraction of 13. The MR sequences considered are T1 weighted pre-and post-contrast agent, fluid-attenuated inversion recovery (FLAIR) and apparent diffusion coefficient (ADC). Benefit of a re-RT risk score (RRRS), comprising the initial tumour grade, age and the Karnofsky Performance Score was shown to correlate with superior outcome in CIRT and conventional re-RT and was also studied here in parallel. Feature sets - a) RRRS, b) radiomics, c) dosiomics features - were evaluated both separately and combined. Multiple feature selection methods were used independently on the CT, DD and the MR sequences, followed by a stepwise Cox's Proportional Hazard model selection per modality or combination thereof. Multivariable models were ranked by 10-fold cross-validated concordance index (C-I). Results: Compared to the RRRS model (OS/PFS, C-I: 0.68/0.61), the multimodality model considering radiomics and dosiomics features (RD) allowed improved prognostic separation (OS/PFS, C-I: 0.77/0.70). The RD signature consisted of 12 and 10 textural features for the OS and PFS models. Combining the RD model with RRRS yielded the best performance (OS/PFS, C-I: 0.78/0.73). No significant correlation between the textural features and the prescribed dose, tumor grade and volume was found, with the Spearman's correlation coefficient ranging between -0.06 to 0.17. Conclusions: Integrating multimodal information outperforms unimodal prognostic separation of rHGG following CIRT, highlighting the importance to consider biological, physical and morphological data for patient stratification. Prospective validation studies of this multimodal stratifier is warranted.[Table: see text]



Sign in / Sign up

Export Citation Format

Share Document